Aggregate Asset Value: Upstream Bio, Inc. (UPB)
This accompanying price chart illustrates the dynamics of Upstream Bio Inc (UPB) total assets, which stand at 350.82. High barriers to entry in the immunology sector are created by patent protection and colossal drug certification costs. Effective leadership comprising industry experts is strategically investing funds, while delegating research to external CRO centers allows the company to optimize operating expenses and avoid technological dependence on specific laboratories.
Financial and market metric breakdowns for Upstream Bio Corp (UPB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Analysis of all company metrics:Upstream Bio Inc
This indicator reflects the aggregate value of Upstream Bio Inc (UPB) resources, reverse-calculated via return on assets (ROA) to eliminate speculative volatility and assess the inertial scale of capital. The price action of all assets demonstrates the efficiency of implementing robotic bio-screening systems, where steady growth confirms the capitalization of technological superiority over manual labor, guaranteeing the fundamental stability of the Upstream Bio Inc (UPB) business.
Competitor analysis for Upstream Bio Inc
argenx.com (ARGX) - Total Asset Value of Company|BNTX - Company Total Assets|Aggregate Asset Value Abivax|Company Total Assets ADMA|Company Total Assets PTGX (Protagonist Corp)|Aggregate Company Assets Immunovant, Inc.|kiniksa.com - Aggregate Asset Value|GRFS: Aggregate Company Assets|ADPT - Cumulative Company Assets|CLDX: Company Total Assets|Company Total Assets Aurinia Corp|BCRX - Cumulative Company Assets|Aggregate Asset Value veratx.com|DNTH (Dianthus Therapeutics, Inc.) - Company Total Assets|Company Total Asset Base PHVS (Pharvaris NV)|abcellera.com - Aggregate Company Assets|Tourmaline - Cumulative Company Assets|PGEN: Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|NKTR: Cumulative Company Assets|ZBIO (Zenas Bio) - Company Total Assets|Aggregate Company Assets Immunome Corp (IMNM)|Total Business Assets Gossamer Bio Corp.|KalVista Pharmaceuticals - Company Total Assets|Company Assets septerna.com SEPN|Cumulative Company Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc - Company Total Assets|Aggregate Company Assets Rigel Pharmaceuticals Inc|ANAB: Total Asset Value of Company|Astria Therapeutics - Aggregate Company Assets|Company Total Asset Base engene.com|RAPT Therapeutics (RAPT) - Cumulative Company Assets|Aggregate Business Assets JBIO|Aclaris (ACRS) - Aggregate Company Assets|Aggregate Asset Value Kyverna Therapeutics, Inc (KYTX)|TLSA: Company Total Assets|Company Assets cabalettabio.com CABA|Ventyx Biosciences, Inc. - Company Total Assets|THTX: Company Total Assets|AVTX (Avalo Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Eledon Pharmaceuticals, Inc|AGEN - Cumulative Company Assets|Aggregate Asset Value climbbio.com|Company Total Assets Zura Bio (ZURA)|Aggregate Company Assets aTyr Pharma Inc (ATYR)|Company Total Assets ADAG|ImageneBio - Company Total Asset Base|STTK (Shattuck Therapeutics) - Aggregate Company Assets|Equillium, Inc. (EQ) - Company Assets|Cumulative Company Assets connectbiopharm.com CNTB|Immunic (IMUX) - Aggregate Asset Value|ATRA: Company Total Assets|Company Total Asset Base IFRX|Aggregate Company Assets X4 Pharmaceuticals XFOR|Total Business Assets adicetbio.com (ACET)|Celularity - Company Total Assets|INMB - Cumulative Company Assets|Barinthus Bio - Cumulative Company Assets|KZR: Company Total Assets|Aggregate Company Assets SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Total Asset Value of Company|Company Total Assets Enlivex Therapeutics Ltd|Aggregate Company Assets QTTB|GOVX - Aggregate Company Assets|Total Asset Value of Company Edesa Biotech Corp (EDSA)|Company Total Assets iBio, Inc.|Aggregate Asset Value Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT: Company Total Assets|Aggregate Company Assets hcwbiologics.com HCWB|APVO (Aptevo Therapeutics Inc.) - Aggregate Asset Value|Aggregate Company Assets AIM|Cumulative Company Assets Aditxt Corp|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc XRTX|Cumulative Company Assets ReShape Lifesciences|Aggregate Asset Value Revelation Biosciences Corp REVB|Company Total Assets INDP (Indaptus Therapeutics)|SCNI: Company Total Asset Base|CALI (calcimedica.com) - Aggregate Company Assets|AFMD (Affimed N.V.) - Cumulative Company Assets|Aggregate Company Assets ALLK|Cumulative Company Assets HOOKIPA (HOOK)|Cumulative Company Assets IGMS|Company Total Assets ITOS (iteostherapeutics.com)|OCEA - Aggregate Company Assets|Total Business Assets TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Company Total Assets